Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF reported earnings results for the full year ended April 30, 2023. For the full year, the company reported revenue was USD 4.61 million. Net income was USD 8.3 million.
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF
Equities
PJP
US46137V6627
Investment Trusts
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.28 USD | -0.14% | -1.58% | +12.60% |
1st Jan change | Capi. | |
---|---|---|
+9.20% | 14.79B | |
+8.06% | 6.55B | |
+15.41% | 4.52B | |
+12.82% | 4.46B | |
-4.92% | 4.14B | |
+2.87% | 3.54B | |
+11.77% | 3.37B | |
+10.56% | 3.14B | |
+14.78% | 2.85B |
- Stock Market
- Equities
- PJP Stock
- News Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF
- Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended April 30, 2023